A Possible New Diagnostic Biomarker in Early Diagnosis of Alzheimer's Disease

Publisher： Bentham Science Publishers

E-ISSN： 1875-5828|6|6|519-524

ISSN： 1567-2050

Source： Current Alzheimer Research, Vol.6, Iss.6, 2009-12, pp. : 519-524

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Early Diagnosis of Alzheimer's Disease.

By Brown J.  

Brain, Vol. 123, Iss. 12, 2000-12 ,pp. : 2567-2568

Oxford University Press

Access to resources Recommend Favorite

Maximizing the Potential of Plasma Amyloid-Beta as a Diagnostic Biomarker for Alzheimer's Disease

By Oh Esther  

NeuroMolecular Medicine, Vol. 10, Iss. 3, 2008-09 ,pp. : 195-207

Humana Press, Inc

Access to resources Recommend Favorite

Serum Glutamine Synthetase Has No Value as a Diagnostic Biomarker for Alzheimer's Disease

By Vermeiren Yannick  

Neurochemical Research, Vol. 36, Iss. 10, 2011-10 ,pp. : 1858-1862

Springer Publishing Company

Access to resources Recommend Favorite

Cerebrospinal Fluid proNGF: A Putative Biomarker for Early Alzheimer’s Disease

By  

Current Alzheimer Research, Vol. 13, Iss. 7, 2016-07 ,pp. : 800-808

Bentham Science Publishers

Access to resources Recommend Favorite

Amyloid Beta-Weighted Cortical Thickness: A New Imaging Biomarker in Alzheimer's Disease

By  

Current Alzheimer Research, Vol. 12, Iss. 6, 2015-01 ,pp. : 563-571

Bentham Science Publishers

Access to resources Recommend Favorite